文献速递免疫规划卫生政策与健康促进

疫苗递送途径对流感疫苗接种中免疫印记的影响

Influence of vaccine delivery route on immune imprinting in influenza vaccination.
PubMed 文献 · Vaccine · 2026-09-07

本文综述流感免疫印记(原始抗原罪)的机制基础,并探讨疫苗递送途径如何调节已形成的印记反应。作者指出,目前基本缺乏直接证据表明接种途径能重编程既有印记;现有数据多显示途径依赖的抗体分区、同种型与解剖定位差异,并提出抗原设计、佐剂与途径整合的设计空间。

要点

  • 现有证据多为途径依赖的抗体分区与定位差异,而非印记重编程。
  • 不同途径募集不同抗原呈递细胞网络与淋巴结构,可能影响克隆选择。
  • 需在试验中纳入免疫史、表位解析与黏膜读出以评估印记终点。

核心结论

  • 疫苗递送途径可能调节流感免疫印记的表达,但直接证据表明其能重编程既有印记者基本缺乏。
  • 合理组合保守抗原、佐剂与接种途径,是拓宽并再平衡印记反应的可行路径。

研究设计与样本

  • 本文为综述,总结流感免疫印记的机制基础及疫苗递送途径对印记反应的潜在调节作用。
  • 文中比较肌内接种与替代策略,并讨论递送途径、抗原设计与佐剂的整合设计空间。

主要发现

  • 生命早期流感暴露可持久偏向后续免疫应答,使其针对初始致敏毒株的表位。
  • 印记限制初始B细胞募集及对漂移或转变病毒的应答广度。
  • 现有数据多显示接种途径依赖的抗体分区、同种型和解剖定位变化。

临床怎么用

  • 开发通用流感疫苗及制定按年龄或免疫史定制的接种策略时,应把接种途径作为设计变量。
  • 评价印记相关终点时宜纳入免疫史、表位解析与黏膜读出。

局限性

  • 缺乏直接证据表明接种途径可改变已建立印记的表位层级或募集初始B细胞克隆。
  • 现有研究对免疫史整合不足,表位解析与黏膜读出使用不充分。
  • 缺乏以印记相关终点为目标的临床试验。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Influenza vaccines are predominantly administered intramuscularly. Yet, their effectiveness remains variable across seasons, age groups, and exposure histories, due to immune imprinting or original antigenic sin. Immune imprinting arises when early-life exposures to influenza durably bias subsequent immune responses toward epitopes from the priming strains. This limits the recruitment of naïve B cells and the breadth of responses to drifted or shifted viruses. As next-generation universal vaccines increasingly focus on conserved antigens and novel platforms, understanding how the vaccination route interacts with imprinting has become a critical but underexplored question. This review summarizes the mechanistic basis of influenza immune imprinting and how the vaccine delivery route might modulate imprinted responses. Importantly, direct evidence that the vaccination route can reprogram established imprinting by changing epitope hierarchy or recruiting naïve B cell clones in primed hosts is essentially lacking; most available data instead demonstrate route-dependent shifts in antibody compartment, isotype, and anatomical localization. We describe the cellular and molecular features of imprinting, and compare intramuscular vaccination with alternative strategies. We emphasize that each route engages distinct antigen-presenting cell networks, lymphoid structures, and systemic versus mucosal compartments, which are likely to influence clonal selection and epitope hierarchy. Further, we discuss the interplay between delivery route, antigen design, and adjuvants as an integrated design space for potentially modulating influenza immunity and the expression of imprinting. We highlight experimental models to analyze route-dependent imprinting and identify key translational gaps, including limited incorporation of immune history, inadequate use of epitope-resolved and mucosal readouts, and lack of clinical trials focused on investigating imprinting-related endpoints. Finally, we outline future directions, arguing that rational combinations of conserved antigens, adjuvants, and routes offer a tractable path to broaden and rebalance imprinted responses. This has direct implications for universal vaccine development and for age- or history-tailored vaccination strategies.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Thakkar V, Aryan Y, Gautam S, et al. Influence of vaccine delivery route on immune imprinting in influenza vaccination. Vaccine. 2026. PMID: 42705168. doi:10.1016/j.vaccine.2026.129109

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。